down arrow

AegirBio AB

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0014401121
SEK
4.53
4.51 (39247.83%)

Dec 04

OME

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About AegirBio AB stock-summary
stock-summary
AegirBio AB
Pharmaceuticals & Biotechnology
Aegirbio AB is a Sweden-based diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's tests for optimized dosage of biological drugs focused on diseases in neurology, autoimmune diseases and cancer.
Company Coordinates stock-summary
Company Details
C/o IDEON SCIENCE PARK, Solvegatan 43 , LUND None : 223 70
stock-summary
Tel:
stock-summary
https://aegirbio.com/
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2024)
Net Profit:
-23 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 34 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.14

stock-summary
Return on Equity

127.53%

stock-summary
Price to Book

-0.87

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."